Pharma Related News
Vektor Pharma: leaders in thin film drug formulations
Vektor Pharma TF GmbH and its team have been leaders in the design, testing, and manufacture of thin film drug formulations.
Vektor Pharma TF GmbH ...
Innovation in drug delivery
We hear from Hugh Rogers of BioNxt Solutions about how the company is driving innovation in drug delivery systems that can support patients with...
Defence Therapeutics begin toxicology study on intranasal AccutoxTM
Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies is pleased to announce the start...
NICE has recommended the anti-cancer drug Enhertu for earlier use
Hundreds more people are now eligible for the breast cancer drug Enhertu as NICE recommends for use in the disease’s early stages
This means NICE...
Defence’s novel Accutox intranasal reduces 50% of cancer nodules
Defence Therapeutics, a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, has just completed a pre-clinical study using...
Extracting medicinal mushrooms
As a result of the rising demand for therapeutic medications, medicinal mushrooms have become increasingly important in healthcare over the last ten years.
The rapid...
Lisdexamfetamine is the safest medication for people with drug addiction
Lisdexamfetamine, a medication for ADHD, has the lowest risk of hospitalisation and death in people with amphetamine addiction, according to research from Karolinska Institutet...
New high blood pressure treatment works on resistant patients
A new drug has been shown to significantly reduce hypertension in patients who do not respond to existing high blood pressure treatment.
According to results...
Making pharma supply chains more sustainable
Nico Ros, Co-Founder and CTO of SkyCell discusses how to make pharma supply chains more sustainable.
As businesses everywhere look for ways to reduce their...
Enhancing the efficacy of cancer vaccines and antibody drug conjugates
In its quest to optimise treatment for cancer and infectious diseases, Defence Therapeutics illustrates how its groundbreaking Accum technology elevates the performance of vaccines...
Study examines the effectiveness of remdesivir in a pill form for COVID-19
Scientists at the University of North Carolina at Chapel Hill are testing remdesivir in a pill form to understand how effective it is for...
Defence Therapeutics: Optimising drug efficacy with AccumTM technology
Health Europa is excited to introduce the latest captivating eBook from industry pioneers of the biotechnology sector, Defence Therapeutics, who comprehensively elucidate their revolutionary...
A new hope for treating neurodegenerative diseases
NervGen’s NVG-291 is a new drug with the potential to treat a range of neurodegenerative diseases, including Alzheimer's and MS.
IT is the Holy Grail...
Trial begins for world-first multivariant COVID-19 vaccine booster
A phase one trial for the world’s first multivariant COVID-19 booster vaccine has been launched in Manchester.
Initiated by pharmaceutical company Gritstone, in partnership with...
Defence Therapeutics unveil novel HPV vaccine development programme
Industry-leading biotechnology company Defence Therapeutics has revealed that it will be establishing a high priority programme to develop a new HPV vaccine for cervical...
Cancer vaccine developed using Oxford-AstraZeneca vaccine technology
Scientists are utilising the same technology used in the creation of the Oxford-AstraZeneca COVID-19 jab to develop a vaccine to treat cancer.
Researchers at the...
Researchers issue opioid warning as they reveal overdose findings
Hundreds of patients could have died from an accidental overdose of prescription opioids, the findings from a recent study have revealed.
Research led by Dr...
AI identifies heart failure patients best suited to beta-blocker treatment
A new AI-based approach could help to quickly and easily identify the best treatment options for heart failure patients.
Researchers from the University of Birmingham...
Defence Therapeutics selects new variants to optimise drug delivery
Following a thorough evaluation process, Defence Therapeutics has selected the eight most successful variants of its Accum™ drug delivery technology.
Biotechnology company Defence Therapeutics continually works...
Lung disease drug offers hope for heart failure patients
A drug currently used to treat lung fibrosis could be repurposed to treat heart failure patients, an early phase trial has suggested.
Doctors and scientists...
